
Alpha Profiles · Company Profile
Atea Pharmaceuticals, Inc.
Canonical company identity and public leadership record.
https://registry.alpha.ac/companies/atea-pharmaceuticals-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: AVIR
- Verification
- Partially verified
- Last reviewed
- 2026-10-22T04:46:27.103907+00:00
Overview
Alpha's canonical identity and public leadership record for Atea Pharmaceuticals, Inc..
Canonical AEGIS identity graph
Executive leadership
Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.
Executive team
6 public recordsChief Financial Officer, Executive Vice President, Legal and Secretary
- State
- confirmed
- Effective
- From Mar 5, 2026
- Confidence
- 94%
- Evidence
- AVIR 10-K executive officersMar 5, 2026
Chief Development Officer
- State
- confirmed
- Effective
- From Mar 5, 2026
- Confidence
- 94%
- Evidence
- AVIR 10-K executive officersMar 5, 2026
President and Chief Executive Officer and Chairman of the Board of Directors
- State
- confirmed
- Effective
- From Mar 5, 2026
- Confidence
- 94%
- Evidence
- AVIR 10-K executive officersMar 5, 2026
Chief Commercial Officer
- State
- confirmed
- Effective
- From Mar 5, 2026
- Confidence
- 94%
- Evidence
- AVIR 10-K executive officersMar 5, 2026
Chief Medical Officer
- State
- confirmed
- Effective
- From Mar 5, 2026
- Confidence
- 94%
- Evidence
- AVIR 10-K executive officersMar 5, 2026
Executive Vice President and Chief Accounting Officer
- State
- confirmed
- Effective
- From Mar 5, 2026
- Confidence
- 94%
- Evidence
- AVIR 10-K executive officersMar 5, 2026
Governance leadership
Boards & Committees
Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.
Record as of Oct 22, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.
Board roles
9 public records- State
- confirmed
- Effective
- From Jan 1, 2025
- Confidence
- 85%
- Evidence
- Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2020
- Confidence
- 85%
- Evidence
- Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2014
- Confidence
- 85%
- Evidence
- Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2014
- Confidence
- 85%
- Evidence
- Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2019
- Confidence
- 85%
- Evidence
- Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2025
- Confidence
- 85%
- Evidence
- Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2014
- Confidence
- 85%
- Evidence
- Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2021
- Confidence
- 85%
- Evidence
- Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29Apr 29, 2025
- State
- confirmed
- Effective
- From Jan 1, 2020
- Confidence
- 85%
- Evidence
- Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29Apr 29, 2025
Committees
3 public recordsMembership and chair roles are projected from current board seats. A chair is shown only when a stored chair flag says so.
Audit
- Chair
- Barbara Duncan
- Members
- Barbara Duncan (Chair); Arthur Kirsch; Bruno Lucidi; Franklin Berger
Compensation
- Chair
- Franklin Berger
- Members
- Franklin Berger (Chair); Bruce W. Polsky, MD, MACP, FIDSA; Bruno Lucidi
Nominating and Governance
- Chair
- Polly A. Murphy, DVM, PhD
- Members
- Polly A. Murphy, DVM, PhD (Chair); Arthur Kirsch; Barbara Duncan; Jerome Adams, MD, MPH
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-10-22T04:46:27.103907+00:00
